M&A TRANSACTION · 2018
Genoptix Inc. acquired by NeoGenomics, Inc.
$138.7M· 1.60x revenue
Target
Genoptix Inc.
Acquirer
NeoGenomics, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$85.0M
EBITDA
—
Deal Value
$138.7M
EV/EBITDA
—
Context
This $138.7M acquisition of Genoptix Inc. by NeoGenomics, Inc. sits in the laboratory services sub-vertical. NeoGenomics, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.
Source
Data sourced from Investor presentations and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Genoptix Inc. acquisition.